Compounds > pergolide
Page last updated: 2024-08-23

pergolide and Parkinson Disease, Secondary

pergolide has been researched along with Parkinson Disease, Secondary in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, N; Fukuyama, J; Isaji, M; Kuno, S; Miyata, H; Mizuta, E1
Burn, DJ; Cartlidge, NE; Chinnery, PF; Cleland, PG; McKeith, I1
Kuno, S; Mizuta, E; Yoshida, O; Yoshimura, N1
Damhaut, P; Dethy, S; Goldman, S; Laute, MA1
Bustos, JC; de Yebenes, JG; Fahn, S; Jackson-Lewis, V; Jorge, P; Lovelle, S; Magariños, C; Martinez, A; Mena, MA; Reiriz, J1

Other Studies

5 other study(ies) available for pergolide and Parkinson Disease, Secondary

ArticleYear
Differential effects of three dopamine receptor agonists in MPTP-treated monkeys.
    Journal of neural transmission. Parkinson's disease and dementia section, 1995, Volume: 10, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Macaca fascicularis; Parkinson Disease, Secondary; Pergolide

1995
Management of parkinsonism and psychotic depression in a case of acute intermittent porphyria.
    Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:5

    Topics: Antiparkinson Agents; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Middle Aged; Parkinson Disease, Secondary; Pergolide; Porphyria, Acute Intermittent; Psychotic Disorders

1997
Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:1

    Topics: Animals; Bromocriptine; Dopamine Agonists; Ergolines; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease, Secondary; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex; Triazoles; Urinary Bladder; Urination

1998
Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine.
    Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Synergism; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Microdialysis; Motor Activity; Neostriatum; Neurons; Oxidopamine; Parkinson Disease, Secondary; Pergolide; Rats; Rats, Wistar

1999
Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:3

    Topics: Animals; Brain; Corpus Striatum; Dopamine; Dopamine Agents; Infusion Pumps; Injections, Intraventricular; Lisuride; Macaca fascicularis; Male; Neural Pathways; Parkinson Disease, Secondary; Pergolide; Rats; Receptors, Dopamine; Selegiline; Stereotyped Behavior; Substantia Nigra

1987